Umb Bank, N.A. Edwards Lifesciences Corp Transaction History

Umb Bank, N.A.

$6.61 Billion
Q3 2025

A detailed history of Umb Bank, N.A. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Umb Bank, N.A. holds 2,460 shares of EW stock, worth $212,298. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,460

Previous 3,019 18.52%

Holding current value

$212,298

Previous $236,000 19.07%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 04, 2025	SELL	$73.75 - $81.83 $41,226 - $45,742	-559 Reduced 18.52%	2,460 $191,000
Q2 2025 Jul 11, 2025	BUY	$67.07 - $78.22 $6,438 - $7,509	96 Added 3.28%	3,019 $236,000
Q1 2025 Apr 14, 2025	SELL	$67.95 - $76.19 $124,824 - $139,961	-1,837 Reduced 38.59%	2,923 $211,000
Q4 2024 Jan 16, 2025	SELL	$64.54 - $75.92 $316,633 - $372,463	-4,906 Reduced 50.76%	4,760 $352,000
Q3 2024 Oct 08, 2024	SELL	$59.7 - $93.78 $6.67 Million - $10.5 Million	-111,752 Reduced 92.04%	9,666 $637,000

Q2 2024 Jul 29, 2024	BUY	$84.3 - $94.31 $316,968 - $354,605	3,760 Added 3.2%	121,418 $11.2 Million
Q1 2024 Apr 26, 2024	BUY	$72.54 - $95.56 $3.42 Million - $4.5 Million	47,130 Added 66.82%	117,658 $11.2 Million
Q4 2023 Jan 23, 2024	BUY	$61.71 - $77.76 $3.62 Million - $4.57 Million	58,737 Added 498.15%	70,528 $5.38 Million
Q3 2023 Oct 18, 2023	SELL	$69.28 - $93.38 $331,920 - $447,383	-4,791 Reduced 28.89%	11,791 $816,000
Q2 2023 Jul 25, 2023	SELL	$81.41 - $94.33 $24,178 - $28,016	-297 Reduced 1.76%	16,582 $1.56 Million
Q1 2023 Apr 11, 2023	SELL	$74.26 - $84.51 $188,100 - $214,063	-2,533 Reduced 13.05%	16,879 $1.4 Million
Q4 2022 Jan 10, 2023	SELL	$68.3 - $87.44 $1.32 Million - $1.69 Million	-19,310 Reduced 49.87%	19,412 $1.45 Million
Q3 2022 Oct 13, 2022	SELL	$82.37 - $107.29 $8.27 Million - $10.8 Million	-100,443 Reduced 72.18%	38,722 $3.2 Million
Q2 2022 Jul 20, 2022	BUY	$86.5 - $128.27 $337,609 - $500,637	3,903 Added 2.89%	139,165 $13.2 Million
Q1 2022 Apr 22, 2022	SELL	$101.96 - $128.34 $13.8 Million - $17.4 Million	-135,736 Reduced 50.09%	135,262 $15.9 Million
Q4 2021 Feb 09, 2022	BUY	$106.37 - $130.68 $2.99 Million - $3.68 Million	28,151 Added 11.59%	270,998 $35.1 Million
Q3 2021 Oct 18, 2021	BUY	$102.91 - $122.75 $528,237 - $630,075	5,133 Added 2.16%	242,847 $27.5 Million
Q2 2021 Jul 26, 2021	SELL	$83.84 - $104.76 $21,630 - $27,028	-258 Reduced 0.11%	237,714 $24.6 Million
Q1 2021 Apr 15, 2021	BUY	$78.68 - $90.67 $751,787 - $866,351	9,555 Added 4.18%	237,972 $19.9 Million
Q4 2020 Feb 04, 2021	BUY	$71.69 - $91.23 $12.4 Million - $15.8 Million	173,165 Added 313.41%	228,417 $20.8 Million
Q2 2020 Jul 16, 2020	BUY	$57.54 - $76.95 $3.18 Million - $4.25 Million	55,252 New	55,252 $3.82 Million

Others Institutions Holding EW

# of Institutions

1,461

Shares Held

468M

Call Options Held

3.46M

Put Options Held

4.07M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $53.4B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Umb Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Umb Bank, N.A. with notifications on news.

Account